HORMEL FOODS CORP
$22.77
-0.13%
Hormel Foods entered a definitive agreement to sell its whole-bird turkey business to Life-Science Innovations (LSI), with closing expected by end of fiscal Q2 2026. Q1 FY2026 EPS of $0.34 beat estimates of $0.32, with revenue of $3.03B slightly below the $3.07B estimate; Foodservice and International segments drove performance offsetting Retail weakness. FY2026 guidance stands at $1.43-$1.51 adjusted EPS (4-10% growth), and 4 analysts recommend buying with an average target of $27.63 vs. current price of $22.70.